Navigation Links
NxStage Reports Record Fourth Quarter and Full-Year 2012 Financial Results
Date:2/28/2013

(15,153)$

(21,402)Net loss per share, basic and diluted

$

(0.04)$

(0.08)$

(0.26)$

(0.39)Weighted-average shares outstanding, basic and diluted

59,07654,99757,89054,217Other comprehensive loss:Foreign currency gain (loss)

$

61$

(210)$

125$

(136)Other (loss) gain

(110)(4)413(17)Comprehensive loss

$

(2,413)$

(4,778)$

(14,615)$

(21,555) 

 NxStage Medical, Inc.Consolidated Balance Sheets(in thousands, except share data)(unaudited)December 31,20122011ASSETSCurrent assets:Cash and cash equivalents

$

106,439$

102,909Accounts receivable, net

18,99015,808Inventory

33,50432,775Prepaid expenses and other current assets

2,5342,777Total current assets

161,467154,269Property and equipment, net

36,32017,599Field equipment, net

10,10112,182Deferred cost of revenues

38,02841,132Intangible assets, net

19,81922,615Goodwill

42,42142,698Other assets

3,7931,213Total assets

$

311,949$

291,708LIABILITIES AND STOCKHOLDERS' EQUITYCurrent liabilities:Accounts payable

$

16,645$

15,634Accrued expenses

20,40015,165Other current liabilities

2,187—Total current liabilities

39,23230,799Deferred revenues

59,26257,014Long-term debt

—43,235Other long-term liabilities

15,8649,474Total liabilities

114,358140,522Commitments and contingenciesStockholders' equity:Undesignated preferred stock: par value $0.001, 5,000,000 shares authorized;  no shares issued and outstanding as of December 31, 2012 and 2011

——Common stock: par value $0.001, 100,000,000 shares authorized; 59,850,117 and 56,167,090 shares issued as of December 31, 2012 and 2011, respectively


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Study Shows NxStage Daily Home Hemodialysis Patients More Likely to Receive Kidney Transplant
2. Former NxStage Patient Nikolas Gieske Celebrates Kidney Transplant
3. FREEDOM Study Data: Patients Experience Sustained Quality of Life Benefits with More Frequent Home Hemodialysis with the NxStage System One
4. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2012
5. NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. NxStage Patient and Advocate Brian Hess Receives Prestigious Honor from American Association of Kidney Patients
7. NxStage Submits Formal Comments to CMS to Improve Patient Access to Life-changing More Frequent Home Hemodialysis Therapy
8. NxStage Names Todd M. Snell Senior Vice President of Quality Assurance, Regulatory & Clinical Affairs
9. NxStage Reports Record Revenue for the Third Quarter of Fiscal 2012
10. NxStage Announces Fourth Quarter 2012 Investor Conference Schedule
11. Robert Funari Joins NxStage Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... , July 28, 2014  A prospective study ... Sweden has validated the performance of ... and has associated volumetrically assessed breast density measurements ... Epidemiology, Biomarkers & Prevention (DOI: 10.1158/1055-9965.EPI-13-1219), the ... tool for widespread breast cancer risk assessment," was ...
(Date:7/28/2014)... , July 28, 2014  Syneron Medical Ltd. (NASDAQ: ... company, announced today that its new PicoWay® device has ... types and colors and pigmented lesions on any skin ... device, with 532nm and 1064nm wavelengths, which utilizes Syneron,s ... using pulses which are trillionths of a second, known ...
(Date:7/28/2014)... MONACO , 28 luglio 2014 ResMed ... sviluppo di prodotti per la cura dei disturbi respiratori ... respiratorio, ha avuto un,ingiunzione permanente in Germania contro il ... che proibisce la vendita di apparecchiature da indossare in ... 210 e le maschere 220. La sentenza della Corte ...
Breaking Medicine Technology:Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 2Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 3Karolinska Study Published in Cancer Epidemiology, Biomarkers & Prevention Validates Strong Agreement for VolparaDensity across Mammography Systems from Multiple Manufacturers 4Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2
... VioQuest,Pharmaceuticals (OTC Bulletin Board: VQPH) today ... of Lenocta(TM) (sodium stibogluconate), a novel,protein tyrosine ... immune stimulant approved for the treatment of ... cancers. The open-label Phase IIa study is,designed ...
... CuraGen Corporation,(Nasdaq: CRGN ), a clinical-stage biopharmaceutical ... Exchange: TOPO) announced,today that updated preliminary clinical trial ... T-cell lymphomas, and new preclinical data,evaluating belinostat on ... 2007 American Society of Hematology (ASH) 49th Annual ...
Cached Medicine Technology:VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 2VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 3VioQuest Pharmaceuticals Announces Dosing of First Patient in Phase IIa Solid Tumor Study for Lenocta(TM), a Novel Protein Tyrosine Phosphatase Inhibitor 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 2CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 3CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 4CuraGen and TopoTarget Announce Presentations on Belinostat at the Upcoming American Society of Hematology 49th Annual Meeting 5
(Date:7/28/2014)... Thousands of DePuy Pinnacle hip lawsuits ... who were allegedly injured by a metal-on-metal version of ... in U.S. District Court, Northern District of Texas, Bernstein ... July 18, 2014, U.S. District Judge Ed Kinkeade has ... Steering Committee that sought the deposition of a witness ...
(Date:7/28/2014)... HealthDay Reporter MONDAY, July 28, ... at risk of contracting meningitis because of specific health ... updated recommendations from the largest pediatrician group in the ... potentially deadly infection should continue for adolescents and college ... its first statement on meningococcal vaccines since 2011, the ...
(Date:7/28/2014)... do not divide unless there is enough oxygen present ... other cell types circumvent this rule. Researchers at The ... overrides the cells, warning signals, enabling cancers to continue ... the process, the researchers found that lysosomes the ... decisions. They also uncovered new evidence that certain drugs ...
(Date:7/28/2014)... you,ve ordered at a restaurantor when something captures ... brain. , These waves are called gamma ... excitatory and inhibitoryplaying together in an orchestrated way. ... have been associated with higher-level brain function, and ... schizophrenia, Alzheimer,s disease, autism, epilepsy and other disorders. ...
(Date:7/28/2014)... 28, 2014 Mirena IUD lawsuits ( ... caused some users to suffer serious injuries after it ... continue to mount in U.S. courts, Bernstein Liebhard LLP ... last month in New Jersey, at least 924 Mirena ... litigation underway in Bergen County Superior Court. Some 148 ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 2Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 3Health News:DePuy Pinnacle Lawsuit News: New Order Issued in Federal Pinnacle Hip Implant Litigation, Bernstein Liebhard LLP Reports 4Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 2Health News:Doctors Urge Meningitis Shots for Vulnerable Infants, Children 3Health News:Cell's recycling center implicated in division decisions 2Health News:Memory relies on astrocytes, the brain's lesser known cells 2Health News:Memory relies on astrocytes, the brain's lesser known cells 3Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 3Health News:Mirena IUD Lawsuit Filings Exceed 920 in New Jersey Litigation, Bernstein Liebhard LLP Reports 4
... -- Chindex International,(Nasdaq: CHDX ) today announced ... for the Ernst & Young Entrepreneur Of The ... to Ernst & Young LLP, the awards,program recognizes ... innovation, financial performance and personal commitment to,their businesses ...
... Atlas Spine, Inc., a spinal,technology development company ... today the national launch of the STATURE Vertebral ... MIS compatible spacer,system designed to utilize a self-distracting ... thoracic and lumbar spine., "After significant developmental ...
... new, highly-advanced walking robot: Flame. This type of research, for ... is important as it provides insight into how people walk. ... improved diagnoses, training and rehabilitation equipment. , If you try ... how complex an activity it is. Walking robots have been ...
... Ontario implements a ban on the retail display of ... Research Unit at the University of Toronto shows that ... point of sale. , Places where tobacco is sold ... communicate with current, former and potential smokers through large ...
... GENERATION OF SCIENTISTS, ELIZABETH, N.J., May 22 ... announced today the,establishment of the Alliance/Merck Ciencia Scholars ... higher education and,degrees in science, technology, engineering and ... $4 million grant from The Merck Company Foundation,the ...
... pioneering research with counselors June 6; provides CEUs, ... to a Ph.D. with the,last name of "Trotter," ... a horse can be more beneficial than traditional ... with other,mental health professionals during her premier Equine ...
Cached Medicine News:Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 2Health News:Chindex International, CEO, Roberta Lipson Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in Greater Washington 3Health News:Atlas Spine Launches Stature(TM) Vertebral Body Replacement System 2Health News:TU Delft robot Flame walks like a human 2Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 2Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 3Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 4Health News:Elizabeth, NJ Chosen for Alliance/Merck Ciencia (Science) Hispanic Scholars Program 5Health News:Equine Partners in Counseling (EPIC) Training Is Changing the Face of Mental Health 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: